§ 13F · FUND PROFILE
Ikarian Capital, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 174Turnover · — · Q4Filed · Feb 18, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$1280.9T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 18, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | XBI | SPDR SERIES TRUST | 850K | $103.6T | 8.1% | NEW |
| 2 | CDTX | CIDARA THERAPEUTICS INC | 300K | $66.3T | 5.2% | NEW |
| 3 | AMGN | AMGEN INC | 200K | $65.5T | 5.1% | NEW |
| 4 | TERN | TERNS PHARMACEUTICALS INC | 1.60M | $64.5T | 5.0% | NEW |
| 5 | CDTX | CIDARA THERAPEUTICS INC | 273K | $60.4T | 4.7% | NEW |
| 6 | ABVX | ABIVAX SA | 206K | $29.1T | 2.3% | NEW |
| 7 | JAZZ | JAZZ PHARMACEUTICALS PLC | 170K | $28.9T | 2.3% | NEW |
| 8 | JAZZ | JAZZ PHARMACEUTICALS PLC | 160K | $27.3T | 2.1% | NEW |
| 9 | MAZE | MAZE THERAPEUTICS INC | 645K | $26.7T | 2.1% | NEW |
| 10 | PRAX | PRAXIS PRECISION MEDICINES I | 87K | $25.5T | 2.0% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE IKARIAN SIGNAL
AC read
Ikarian Capital, LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed